Hexadox Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.41 M
- Revenue Growth 1838.80%
- Profit Growth 2264.50%
- Ebitda 1947.08%
- Net Worth 514.60%
- Total Assets 593.20%
About Hexadox Pharmaceuticals
Hexadox Pharmaceuticals Private Limited (HPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 August 2020 (Four years and six months 6 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹1.41 M.
Manojkumar Parekh, Ravindra Puligundla, Sudheendra Udbalker, and Three other members serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24290KA2020PTC137152
-
Company No.
137152
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2020
-
Date of AGM
19 Jul 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Hexadox Pharmaceuticals?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojkumar Parekh
|
Director | 12-Aug-2020 | Current |
|
Ravindra Puligundla
|
Director | 12-Aug-2020 | Current |
|
Sudheendra Udbalker
|
Director | 12-Aug-2020 | Current |
|
Venkatapathibhatta Rajkumar
|
Director | 12-Aug-2020 | Current |
|
Lokesh Rao
|
Director | 25-Sep-2020 | Current |
|
Belliappa Alamengada
|
Director | 25-Sep-2020 | Current |
Financial Performance of Hexadox Pharmaceuticals.
Hexadox Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1838.8% increase. The company also saw a substantial improvement in profitability, with a 2264.5% increase in profit. The company's net worth Soared by an impressive increase of 514.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hexadox Pharmaceuticals?
Unlock access to Hexadox Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Krian Healthcare Private LimitedSudheendra Udbalker is a mutual person
Charges (Loans)
₹1.41 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2023 | Hdfc Bank Limited | ₹1.41 M | Open |
How Many Employees Work at Hexadox Pharmaceuticals?
Hexadox Pharmaceuticals has a workforce of 15 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hexadox Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hexadox Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.